|
GO accession | Biological process | NES | value |
|
GO:0006576 | Cellular biogenic amine metabolic process | 1.33 | 2.63E − 02 |
GO:0044106 | Cellular amine metabolic process | 1.33 | 2.63E − 02 |
GO:0046885 | Regulation of hormone biosynthetic process | −1.40 | 3.17E − 02 |
GO:0051004 | Regulation of lipoprotein lipase activity | −1.32 | 3.28E − 02 |
GO:0070874 | Negative regulation of glycogen metabolic process | −1.44 | 3.39E − 02 |
GO:0032106 | Positive regulation of response to extracellular stimulus | −1.48 | 3.45E − 02 |
GO:0032109 | Positive regulation of response to nutrient levels | −1.48 | 3.45E − 02 |
GO:0031442 | Positive regulation of mRNA 3′-end processing | −1.24 | 3.57E − 02 |
GO:0043001 | Golgi to plasma membrane protein transport | −1.41 | 3.64E − 02 |
GO:2000973 | Regulation of pro-B cell differentiation | −1.69 | 3.77E − 02 |
GO:0032494 | Response to peptidoglycan | 1.40 | 3.85E − 02 |
GO:0006400 | tRNA modification | 1.50 | 3.92E − 02 |
GO:0045807 | Positive regulation of endocytosis | −1.34 | 4.11E − 02 |
GO:0006970 | Response to osmotic stress | −1.15 | 4.17E − 02 |
GO:0090199 | Regulation of release of cytochrome c from mitochondria | 1.29 | 4.35E − 02 |
GO:0042953 | Lipoprotein transport | −1.18 | 4.35E − 02 |
GO:0044872 | Lipoprotein localization | −1.18 | 4.35E − 02 |
GO:0061418 | Regulation of transcription from RNA polymerase II promoter in response to hypoxia | −1.52 | 4.35E − 02 |
GO:0048644 | Muscle organ morphogenesis | −1.70 | 4.35E − 02 |
GO:0022615 | Protein to membrane docking | −1.49 | 4.41E − 02 |
GO:0035563 | Positive regulation of chromatin binding | 1.55 | 4.44E − 02 |
GO:0048259 | Regulation of receptor-mediated endocytosis | −1.25 | 4.48E − 02 |
GO:0032922 | Circadian regulation of gene expression | −1.25 | 4.55E − 02 |
GO:0006694 | Steroid biosynthetic process | −1.37 | 4.55E − 02 |
GO:2001014 | Regulation of skeletal muscle cell differentiation | −1.57 | 4.55E − 02 |
GO:2000641 | Regulation of early endosome to late endosome transport | −1.31 | 4.62E − 02 |
GO:0043112 | Receptor metabolic process | −1.25 | 4.69E − 02 |
GO:0006891 | Intra-Golgi vesicle-mediated transport | −1.38 | 4.69E − 02 |
GO:0035330 | Regulation of hippo signalling | −1.44 | 4.69E − 02 |
GO:0035640 | Exploration behavior | −1.47 | 4.69E − 02 |
GO:0006270 | DNA replication initiation | 1.46 | 4.76E − 02 |
GO:0031536 | Positive regulation of exit from mitosis | 1.29 | 4.76E − 02 |
GO:0048020 | CCR chemokine receptor binding | −1.41 | 4.76E − 02 |
GO:0017144 | Drug metabolic process | −1.42 | 4.76E − 02 |
GO:2000095 | Regulation of Wnt signalling pathway, planar cell polarity pathway | −1.69 | 4.76E − 02 |
GO:0042347 | Negative regulation of NF-kappaB import into nucleus | −1.37 | 4.84E − 02 |
GO:0046854 | Phosphatidylinositol phosphorylation | −1.38 | 4.84E − 02 |
GO:0006901 | Vesicle coating | −1.42 | 4.84E − 02 |
GO:0051045 | Negative regulation of membrane protein ectodomain proteolysis | 1.62 | 4.88E − 02 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 1.51 | 4.88E − 02 |
GO:0034723 | DNA replication-dependent nucleosome organization | 1.51 | 4.88E − 02 |
GO:2000649 | Regulation of sodium ion transmembrane transporter activity | −1.33 | 4.92E − 02 |
GO:0048260 | Positive regulation of receptor-mediated endocytosis | −1.35 | 4.92E − 02 |
GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | −1.36 | 4.92E − 02 |
GO:0018879 | Biphenyl metabolic process | −1.45 | 4.92E − 02 |
|